Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2017 $ 12,162 $ 2,943 $ 48 $ 109,708 $ (97,595) $ 2,943 $ 1
Beginning balance, Shares at Dec. 31, 2017     9,827,129        
Exercise of stock options $ 550   $ 3 547      
Exercise of stock options, Shares 609,985   609,985        
Issuance of common stock in connection with exercise of warrants $ 988   $ 1 987      
Issuance of common stock in connection with exercise of warrants, Shares     296,691        
Issuance of common stock from ESPP purchase 909     909      
Issuance of common stock from ESPP purchase, Shares     83,605        
Issuance of common stock from RSU's vested 2   $ 3 (1)      
Issuance of common stock from RSU's vested, Shares     47,312        
Stock-based compensation 2,468     2,468      
Foreign currency translation gain (loss) (150)           (150)
Net income (loss) (2,725)       (2,725)    
Ending balance at Dec. 31, 2018 17,147   $ 55 114,618 (97,377)   (149)
Ending balance, Shares at Dec. 31, 2018     10,864,722        
Exercise of stock options $ 454   $ 2 452      
Exercise of stock options, Shares 307,365   307,365        
Issuance of common stock in connection with exercise of warrants $ 71     71      
Issuance of common stock in connection with exercise of warrants, Shares     26,098        
Issuance of common stock upon secondary offering, net of costs 10,554   $ 1 10,553      
Issuance of common stock upon secondary offering, net of costs, Shares     250,000        
Repurchase of common stock and retirement (6,718)   $ (2) (6,716)      
Repurchase of common stock and retirement, Shares     (257,824)        
Repurchase of common stock $ (6,700)            
Repurchase of common stock, Shares (257,824)            
Issuance of common stock from ESPP purchase $ 873   $ 1 872      
Issuance of common stock from ESPP purchase, Shares     65,639        
Issuance of common stock from RSU's vested, Shares     58,150        
Stock-based compensation 3,057     3,057      
Foreign currency translation gain (loss) 15           15
Net income (loss) 1,798       1,798    
Ending balance at Dec. 31, 2019 27,251   $ 57 122,907 (95,579)   (134)
Ending balance, Shares at Dec. 31, 2019     11,314,150        
Exercise of stock options $ 314   $ 1 313      
Exercise of stock options, Shares 96,456   96,456        
Issuance of common stock in connection with exercise of warrants, Shares     46,939        
Repurchase of common stock $ (1,615)     (1,615)      
Repurchase of common stock, Shares (74,520)   (74,520)        
Issuance of common stock from ESPP purchase $ 704     704      
Issuance of common stock from ESPP purchase, Shares     37,102        
Issuance of common stock from RSU's vested, Shares     54,970        
Issuance of common stock from acquisition 2,000     2,000      
Issuance of common stock from acquisition, Shares     63,901        
Stock-based compensation 4,462     4,462      
Foreign currency translation gain (loss) (36)           (36)
Net income (loss) 1,225       1,225    
Ending balance at Dec. 31, 2020 $ 34,305   $ 58 $ 128,771 $ (94,354)   $ (170)
Ending balance, Shares at Dec. 31, 2020     11,538,998